Technology industry giant and Groupon co-founder Eric Lefkofsky is now co-founder of the healthcare startup Tempus. Tempus is an innovative technology company that is developing solutions for new cancer treatments within a robotic lab. Revolution Growth and New Enterprise Associates collectively invested $70 million into the series C funding of Tempus. Eric Lefkofsky is hopeful that the total $130 million in funding will propel Tempus towards developing life-saving strategies in the future treatment of cancer.

A loved one’s diagnosis with cancer was the motivation of starting Tempus, and nurturing the collection of genetic and clinical data in order to advance the method of genomic sequencing is well worth Lefkofsky’s time. The tech billionaire started Tempus in 2015 and has invested his own money in each round of fundraising. Helping people have an optimal chance of beating cancer is a cause that is close to Lefkofsky’s heart. The desire for the advancement of oncology treatment is shared by Tempus partners including Duke University School of Medicine and the Mayo Clinic.

The life of Eric Lefkofsky is dynamic and charitable. The contributions Lefkofsky has made to humanity and the business world are many. Lefkofsky is also, along with Tempus, co-founder of Uptake Technologies, Echo Global Logistics, InnerWorkings, and Lightbank. Started by Eric Lefkofsky and his wife, The Lefkofsky Family Foundation is a private charity that was created to contribute to the progression of numerous communities. The Lefkofsky’s roles as philanthropists continue further by donating to cancer care organizations such as Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Weill Cornell Medicine. Eric Lefkofsky sits on the Board of Trustees for Lurie Children’s Hospital of Chicago and is Chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company.